Bernardo Boris Vargaftig
Bernardo Boris Vargaftig
Professor Titular Aposentado do Departamento de Farmacologia do Instituto de Ciências Biomédicas da Universidade de São Paulo
Verified email at
Cited by
Cited by
Perspectives in platelet-activating factor research.
P Braquet, L Touqui, TY Shen, BB Vargaftig
Pharmacological Reviews 39 (2), 97-145, 1987
The role of platelet-activating factor in platelet aggregation
M Chignard, JP Le Couedic, M Tence, BB Vargaftig, J Benveniste
Nature 279 (5716), 799-800, 1979
Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives
BB Vargaftig, J Lefort, M Chignard, J Benveniste
European journal of pharmacology 65 (2-3), 185-192, 1980
Background and present status of research on platelet‐activating factor (PAF‐acether)
BB Vargaftig, M Chignard, J Benveniste, J Lefort, F Wal
Annals of the New York Academy of Sciences 370 (1), 119-137, 1981
Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model
M Lisbonne, S Diem, A de Castro Keller, J Lefort, LM Araujo, P Hachem, ...
The Journal of Immunology 171 (4), 1637-1641, 2003
Present concepts on the mechanisms of platelet aggregation
BB Vargaftig, M Chignard, J Benveniste
Biochemical pharmacology 30 (4), 263-271, 1981
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
C Zuany-Amorim, S Haile, D Leduc, C Dumarey, M Huerre, BB Vargaftig, ...
The Journal of clinical investigation 95 (6), 2644-2651, 1995
Requirement for γδ T cells in allergic airway inflammation
C Zuany-Amorim, C Ruffie, S Haile, BB Vargaftig, P Pereira, M Pretolani
Science 280 (5367), 1265-1267, 1998
Murine models of asthma
JC Kips, GP Anderson, JJ Fredberg, U Herz, MD Inman, M Jordana, ...
European Respiratory Journal 22 (2), 374-382, 2003
Platelet activation—a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin
L Touqui, B Rothhut, AM Shaw, A Fradin, BB Vargaftig, F Russo-Marie
Nature 321 (6066), 177-180, 1986
Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin
BB Vargaftig, ND Hai
Journal of Pharmacy and Pharmacology 24 (2), 159-161, 1972
Platelet‐activating factor (PAF‐acether) secretion from platelets: effect of aggregating agents
M Chignard, JPL Couedic, BB Vargaftig, J Benvenisie
British journal of haematology 46 (3), 455-464, 1980
Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2
BB Vargaftig, P Zirinis
Nature New Biology 244, 114-116, 1973
Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration: modulation by prostacyclin, platelet depletion, and selective antagonists
A Lellouch-Tubiana, J Lefort, MT Simon, A Pfister, BB Vargaftig
American Review of Respiratory Disease, 2012
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat: effects of three platelet-activating factor antagonists
JL Wallace, G Steel, BJR Whittle, V Lagente, B Vargaftig
Gastroenterology 93 (4), 765-773, 1987
Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity
D Rodríguez, AC Keller, EL Faquim-Mauro, MS de Macedo, FQ Cunha, ...
The Journal of Immunology 171 (2), 1001-1008, 2003
Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways.
M Pretolani, C Ruffie, JR Lapa e Silva, D Joseph, RR Lobb, BB Vargaftig
The Journal of experimental medicine 180 (3), 795-805, 1994
A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma
M Singer, LD Martin, BB Vargaftig, J Park, AD Gruber, Y Li, KB Adler
Nature medicine 10 (2), 193-196, 2004
Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness.
SY Eum, S Haile, J Lefort, M Huerre, BB Vargaftig
Proceedings of the National Academy of Sciences 92 (26), 12290-12294, 1995
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 …
L Arbibe, K Koumanov, D Vial, C Rougeot, G Faure, N Havet, S Longacre, ...
The Journal of clinical investigation 102 (6), 1152-1160, 1998
The system can't perform the operation now. Try again later.
Articles 1–20